HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Suspène, R. Articles by Vartanian, J.-P. Search for Related Content PubMed PubMed Citation Articles by Suspène, R. Articles by Vartanian, J.-P. Agricola Articles by Suspène, R. Articles by Vartanian, J.-P.

Recovery of APOBEC3-edited human immunodeficiency virus GA hypermutants by differential DNA denaturation PCR

¹ Unité de Rétrovirologie Moléculaire, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France
² Unité de Recherche Prévention et Thérapie moléculaires des Maladies humaines, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France

Correspondence
Jean-Pierre Vartanian
jpvart{at}pasteur.fr

Virus genomes from the same family may exhibit a wide range in their DNA GC content, whereas viral hypermutants differ substantially in GC content from their parental genomes. As AT-rich DNA melts at lower temperatures than GC-rich DNA, use of a lower denaturation temperature during PCR should allow differential amplification of AT-rich genomes or variants within a quasispecies. The latter situation has been explored explicitly in a two-step process by using a series of well-defined viral sequences differing in their AT content. Firstly, the lowest denaturation temperature (T_p) that allowed amplification of the parental sequence was determined. Secondly, differential amplification of AT-rich viral variants was obtained by using a denaturation temperature 1–3 °C lower than T_p. Application of this sensitive method to two different viruses allowed us to identify human immunodeficiency virus type 1 GA hypermutants in a situation where none were expected and to amplify AT-rich variants selectively within a spectrum of poliovirus mutants.

This article has been cited by other articles:

				R. Suspene, M. Renard, M. Henry, D. Guetard, D. Puyraimond-Zemmour, A. Billecocq, M. Bouloy, F. Tangy, J.-P. Vartanian, and S. Wain-Hobson Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs Nucleic Acids Res., July 1, 2008; 36(12): e72 - e72. [Abstract] [Full Text] [PDF]

				J. Kock and H. E. Blum Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H J. Gen. Virol., May 1, 2008; 89(5): 1184 - 1191. [Abstract] [Full Text] [PDF]

				J.-P. Vartanian, D. Guetard, M. Henry, and S. Wain-Hobson Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions Science, April 11, 2008; 320(5873): 230 - 233. [Abstract] [Full Text] [PDF]

				M. Bonvin and J. Greeve Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro J. Gen. Virol., December 1, 2007; 88(12): 3270 - 3274. [Abstract] [Full Text] [PDF]

				C. Noguchi, N. Hiraga, N. Mori, M. Tsuge, M. Imamura, S. Takahashi, Y. Fujimoto, H. Ochi, H. Abe, T. Maekawa, et al. Dual effect of APOBEC3G on Hepatitis B virus J. Gen. Virol., February 1, 2007; 88(2): 432 - 440. [Abstract] [Full Text] [PDF]

				Y.-L. Chiu and W. C. Greene APOBEC3 Cytidine Deaminases: Distinct Antiviral Actions along the Retroviral Life Cycle J. Biol. Chem., March 31, 2006; 281(13): 8309 - 8312. [Abstract] [Full Text] [PDF]

				F. Delebecque, R. Suspene, S. Calattini, N. Casartelli, A. Saib, A. Froment, S. Wain-Hobson, A. Gessain, J.-P. Vartanian, and O. Schwartz Restriction of Foamy Viruses by APOBEC Cytidine Deaminases J. Virol., January 15, 2006; 80(2): 605 - 614. [Abstract] [Full Text] [PDF]

				R. Mahieux, R. Suspene, F. Delebecque, M. Henry, O. Schwartz, S. Wain-Hobson, and J.-P. Vartanian Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases J. Gen. Virol., September 1, 2005; 86(9): 2489 - 2494. [Abstract] [Full Text] [PDF]

				R. Suspene, D. Guetard, M. Henry, P. Sommer, S. Wain-Hobson, and J.-P. Vartanian Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo PNAS, June 7, 2005; 102(23): 8321 - 8326. [Abstract] [Full Text] [PDF]